1 completed, 1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Krytantek: new trials by email Literature Review of Krytantek trials Research Report on Krytantek
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM) PRO-122, Timolol eye drops, Dorzolamide-Timolol Ophthalmic - Primary Open-angle Glaucoma | Phase 3 | Terminated | Laboratorios Sophia S.A de C.V. | 51 | 2017-11-06 | 2025-03-06 |
| Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Ganforti, Krytantek - Glaucoma Primary Open Angle | Completed | Allergan S.A. DE C.V.. | 90 | 2011-02-01 | 2012-11-30 |
Glaucoma, Open-Angle (2) · Glaucoma (1) · Ocular Hypertension (1)
Allergan S.A. DE C.V.. (1) · Laboratorios Sophia S.A de C.V. (1)
Mexico (2) · Colombia (1)
Jose A Paczka, MD (1) · Karen Ortiz (1) · Leopoldo Baiza, MD (1)